Silver Book Fact

The increase in the stock of cancer drugs from 1975 to 1995 accounted for about 50 to 60 percent of the increase in age-adjusted survival rates in the first 6 years after diagnosis.

The Expanding Pharmaceutical Arsenal in the War on Cancer. NBER Working Paper Series Web site. http://www.nber.org/papers/w10328. Published 2004

Reference

Title
The Expanding Pharmaceutical Arsenal in the War on Cancer
Publication
NBER Working Paper Series
Publication Date
Published 2004
Authors
Lichtenberg F
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Use of tamoxifen, a drug used to treat breast cancer, has resulted in a direct cost savings of $41,372 per year of life gained in women 35- to 49-years-old, $68,349…  
  • The 5-year survival rate for all cancers diagnosed from 1996-2003 is 66%, up from 50% in 1975-1977. This improvement reflects progress in early diagnosis and improvements in treatment.  
  • 750 cancer-fighting medicines are currently in development.  
  • Survival rates for colon cancer went from 41 percent to 63 percent between 1975 and 1995.  
  • A one percent reduction in lung, colorectal, breast, leukemia, pancreatic, and brain cancer mortality would reduce productivity costs by $814 million per year.